Commonly used antihypertensives and lower urinary tract symptoms: Results from the Boston Area Community Health (BACH) Survey

BJU International

Volumn 109, Issue 11, 2012, Pages 1676-1684

  Hall, Susan A ^a   Chiu, Gretchen R ^a   Kaufman, David W ^b   Wittert, Gary A ^c   Link, Carol L ^a   McKinlay, John B ^a  

^a NEW ENGLAND RESEARCH INSTITUTES   (United States)

^b BOSTON UNIVERSITY   (United States)

^c UNIVERSITY OF ADELAIDE   (Australia)

Author keywords

antihypertensive agents; epidemiology; urination disorders

Indexed keywords

ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; LOOP DIURETIC AGENT; THIAZIDE DIURETIC AGENT;

ADULT; AGED; ARTICLE; COMORBIDITY; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG INFORMATION; FEMALE; HEALTH SURVEY; HUMAN; LOWER URINARY TRACT SYMPTOM; MAJOR CLINICAL STUDY; MALE; MICTURITION; NOCTURIA; PRESCRIPTION; PREVALENCE; PRIORITY JOURNAL; PUBLIC HEALTH; QUALITY OF LIFE; QUESTIONNAIRE; RISK FACTOR; TEST RETEST RELIABILITY; UNITED STATES;

ADULT; AGED; ANTIHYPERTENSIVE AGENTS; BOSTON; COHORT STUDIES; FEMALE; HEALTH SURVEYS; HUMANS; HYPERTENSION; LOWER URINARY TRACT SYMPTOMS; MALE; MIDDLE AGED; PREVALENCE; RISK FACTORS; SEX FACTORS;

EID: 84859102146     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2011.10593.x     Document Type: Article

References (37)

1. Litman HJ, McKinlay JB,. The future magnitude of urological symptoms in the USA: projections using the Boston Area Community Health survey. BJU Int 2007; 100: 820-5. Erratum in: BJU Int. 2007 Oct;100(4):971 (Pubitemid 47360166)
2. Kupelian V, Rosen RC, Link CL, et al,. Association of urological symptoms and chronic illness in men and women: contributions of symptom severity and duration-results from the BACH Survey. J Urol 2009; 181: 694-700
3. Joseph MA, Harlow SD, Wei JT, et al,. Risk factors for lower urinary tract symptoms in a population-based sample of African-American men. Am J Epidemiol 2003; 157: 906-14 (Pubitemid 36555050)
4. Rohrmann S, Smit E, Giovannucci E, Platz EA,. Association between markers of the metabolic syndrome and lower urinary tract symptoms in the Third National Health and Nutrition Examination Survey (NHANES III). Int J Obes (Lond) 2005; 29: 310-6 (Pubitemid 40333230)
5. Coyne KS, Zhou Z, Bhattacharyya SK, Thompson CL, Dhawan R, Versi E,. The prevalence of nocturia and its effect on health-related quality of life and sleep in a community sample in the USA. BJU Int 2003; 92: 948-54 (Pubitemid 37548272)
6. Kujubu DA, Aboseif SR,. An overview of nocturia and the syndrome of nocturnal polyuria in the elderly. Nat Clin Pract 2008; 4: 426-35
7. Rosenberg MT, Newman DK, Tallman CT, Page SA,. Overactive bladder: recognition requires vigilance for symptoms. Cleve Clin J Med 2007; 74 (Suppl. 3): S21-9
8. Rosenberg MT, Staskin DR, Kaplan SA, MacDiarmid SA, Newman DK, Ohl DA,. A practical guide to the evaluation and treatment of male lower urinary tract symptoms in the primary care setting. Int J Clin Pract 2007; 61: 1535-46 (Pubitemid 47228616)
9. McKinlay JB, Link CL,. Measuring the urologic iceberg: design and implementation of the boston area community health (BACH) survey. Eur Urol 2007; 52: 389-96 (Pubitemid 46963446)
10. Barry MJ, Fowler FJ Jr, O'Leary MP, et al,. The American Urological Association symptom index for benign prostatic hyperplasia. The Measurement Committee of the American Urological Association. J Urol 1992; 148: 1549-57; discussion 64
11. Badia X, Garcia-Losa M, Dal-Re R, Carballido J, Serra M,. Validation of a harmonized Spanish version of the IPSS: evidence of equivalence with the original American scale. International Prostate Symptom Score. Urology 1998; 52: 614-20 (Pubitemid 28440167)
12. Barry MJ, Fowler FJ Jr, O'Leary MP, Bruskewitz RC, Holtgrewe HL, Mebust WK,. Correlation of the American Urological Association symptom index with self-administered versions of the Madsen-Iversen, Boyarsky and Maine Medical Assessment Program symptom indexes. Measurement Committee of the American Urological Association. J Urol 1992; 148: 1558-63; discussion 64
13. Okamura K, Nojiri Y, Osuga Y, Tange C,. Psychometric analysis of international prostate symptom score for female lower urinary tract symptoms. Urology 2009; 73: 1199-202
14. Fitzgerald MP, Litman HJ, Link CL, McKinlay JB,. The association of nocturia with cardiac disease, diabetes, body mass index, age and diuretic use: results from the BACH survey. J Urol 2007; 177: 1385-9 (Pubitemid 46436009)
15. Kelley KE, Kelley TP, Kaufman DW, Mitchell AA,. The Slone drug dictionary: a research driven pharmacoepidemiology tool. Pharmacoepidemiol Drug Saf 2003; 12: 168-9
16. Hall SA, Chiu GR, Kaufman DW, et al,. General exposures to prescription medications by race/ethnicity in a population-based sample: results from the Boston Area Community Health Survey. Pharmacoepidemiol Drug Saf 2010; 19: 384-92
17. Chobanian AV, Bakris GL, Black HR, et al,. The seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 report. JAMA 2003; 289: 2560-72 (Pubitemid 37430158)
18. Green LW,. Manual for scoring socioeconomic status for research on health behavior. Public Health Rep 1970; 85: 815-27
19. Washburn RA, Smith KW, Jette AM, Janney CA,. The Physical Activity Scale for the Elderly (PASE): development and evaluation. J Clin Epidemiol 1993; 46: 153-62 (Pubitemid 23092124)
20. Grobbee DE, Hoes AW,. Confounding and indication for treatment in evaluation of drug treatment for hypertension. BMJ 1997; 315: 1151-4 (Pubitemid 27470317)
21. Ong KL, Cheung BM, Man YB, Lau CP, Lam KS,. Prevalence, awareness, treatment, and control of hypertension among United States adults 1999-2004. Hypertension 2007; 49: 69-75 (Pubitemid 46360343)
22. Schafer JL,. Analysis of Incomplete Multivariate Data. New York: Chapman & Hall, 1997
23. Kupelian V, Wei JT, O'Leary MP, et al,. Prevalence of lower urinary tract symptoms and effect on quality of life in a racially and ethnically diverse random sample: the Boston Area Community Health (BACH) Survey. Arch Intern Med 2006; 166: 2381-7 (Pubitemid 44833365)
24. Rothman KJ, Greenland S,. Modern Epidemiology, 2nd edn. Philadelphia, PA: Lippincott-Raven Publishers, 1998
25. Hall SA, Link CL, Pulliam SJ, et al,. The relationship of common medical conditions and medication use with symptoms of painful bladder syndrome: results from the Boston Area Community Health Survey. J Urol 2008; 180: 593-8
26. Wegener JW, Schulla V, Lee TS, et al,. An essential role of Cav1.2 L-type calcium channel for urinary bladder function. Faseb J 2004; 18: 1159-61 (Pubitemid 39561556)
27. Sarkar SN, Huang RQ, Logan SM, Yi KD, Dillon GH, Simpkins JW,. Estrogens directly potentiate neuronal L-type Ca2+ channels. Proc Natl Acad Sci USA 2008; 105: 15148-53
28. Batra S,. Interaction of antiestrogens with binding sites for muscarinic cholinergic drugs and calcium channel blockers in cell membranes. Cancer Chemother Pharmacol 1990; 26: 310-2 (Pubitemid 20211121)
29. Ekundayo OJ, Markland A, Lefante C, et al,. Association of diuretic use and overactive bladder syndrome in older adults: a propensity score analysis. Arch Gerontol Geriatr 2009; 49: 64-8
30. Rembratt A, Norgaard JP, Andersson KE,. Nocturia and associated morbidity in a community-dwelling elderly population. BJU Int 2003; 92: 726-30 (Pubitemid 37475815)
31. Bing MH, Moller LA, Jennum P, Mortensen S, Lose G,. Nocturia and associated morbidity in a Danish population of men and women aged 60-80 years. BJU Int 2008; 102: 808-14
32. Alling Moller L, Lose G, Jorgensen T,. Risk factors for lower urinary tract symptoms in women 40 to 60 years of age. Obstet Gynecol 2000; 96: 446-51
33. Johnson TM 2nd, Sattin RW, Parmelee P, Fultz NH, Ouslander JG,. Evaluating potentially modifiable risk factors for prevalent and incident nocturia in older adults. J Am Geriatr Soc 2005; 53: 1011-6 (Pubitemid 41647600)
34. Klein BE, Klein R, Lee KE, Bruskewitz RC,. Correlates of urinary symptom scores in men. Am J Public Health 1999; 89: 1745-8 (Pubitemid 29508227)
35. Felker GM, O'Connor CM, Braunwald E,. Loop diuretics in acute decompensated heart failure: necessary? Evil? A necessary evil? Circ Heart Fail 2009; 2: 56-62
36. Kok ET, Schouten BW, Bohnen AM, Groeneveld FP, Thomas S, Bosch JL,. Risk factors for lower urinary tract symptoms suggestive of benign prostatic hyperplasia in a community based population of healthy aging men: the Krimpen Study. J Urol 2009; 181: 710-6
37. Liu H, Liu P, Mao G, et al,. Efficacy of combined amlodipine/terazosin therapy in male hypertensive patients with lower urinary tract symptoms: a randomized, double-blind clinical trial. Urology 2009; 74: 130-6